Congress Is Taking Important Action To Bring Down Drug Prices For Americans

posted by AHIP

on March 27, 2019

WASHINGTON, D.C. – Matt Eyles, president and CEO of America’s Health Insurance Plans (AHIP), issued the following statement as the House Energy & Commerce Committee began mark-up of essential legislation to bring down drug prices, including the CREATES Act and a bill to end pay-for-delay schemes by Big Pharma:

“Drug prices are out of control, and hardworking American families shouldn’t have to choose between paying their bills and getting the medications they need. The problem is the price: Drug makers set the prices for their medications, they alone increase prices, and they alone can decide to bring down their prices.

“We appreciate that Congress and the Administration have made it a priority to reduce drug prices for all Americans, and we join them in this commitment. We applaud their pursuit of common-sense policy solutions, like the CREATES Act and legislation to eliminate pay-for-delay arrangements, that will help Americans fight back against Big Pharma’s gaming of a broken system for their own financial gain.

“As consumers’ bargaining power, AHIP’s members will continue to fight for lower drug costs for patients. And we will continue to work together with Congress and the Administration to ensure that every American gets the medications they need at a price they can afford.”

Read more about AHIP’s solutions for reducing drug prices.

" "